Dynavax Technologies Corporation (DVAX)

Cash ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash and cash equivalents	US$ in thousands	95,883	150,279	202,004	436,189	32,073
Short-term investments	US$ in thousands	617,951	592,023	422,391	109,761	132,963
Total current liabilities	US$ in thousands	78,634	62,195	150,074	556,402	77,411
Cash ratio		9.08	11.94	4.16	0.98	2.13

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($95,883K + $617,951K) ÷ $78,634K
= 9.08

The cash ratio of Dynavax Technologies Corporation has fluctuated over the past five years. As of December 31, 2020, the company had a cash ratio of 2.13, indicating that it had $2.13 in cash and cash equivalents for every $1 of current liabilities.

However, by December 31, 2021, the cash ratio had decreased to 0.98, suggesting that the company's liquidity position had weakened, with less cash available to cover its short-term obligations.

In the following years, the cash ratio improved significantly, reaching 4.16 by December 31, 2022, 11.94 by December 31, 2023, and 9.08 by December 31, 2024. These higher ratios indicate that the company had substantially increased its cash reserves relative to its current liabilities, enhancing its ability to meet short-term financial obligations.

Overall, the trend in Dynavax Technologies Corporation's cash ratio reflects varying levels of liquidity and suggests that the company made efforts to strengthen its cash position in the later years, which may have improved its financial stability and ability to weather potential financial challenges.